IMPLEMENTATION OF ANTI-TUBERCULOSIS ACTIVITIES AT THE END OF 2021
An analysis of the epidemiological situation with respect to tuberculosis during the years of the coronavirus pandemic revealed the negative impact of COVID-19 on the quality of anti-tuberculosis measures. There is a worsening of the clinical structure of tuberculosis, an increase in the proportion of new cases of tuberculosis with lung tissue destruction and bacterial excretion, an increase in post-mortem tuberculosis cases, an increase in the proportion of deaths among new cases, and a decrease in the effectiveness of tuberculosis treatment.